Skip to content

Circles

S

Skye Bioscience, Inc.

SKYE· Nasdaq

S

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.·Earnings record

Q4 2012

Source filing unavailable

Previous · Q3 2012 Next · Q3 2013

Q4 2012 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived$1,525—

Same quarter

no prior Q4 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q2 ’12 Q3 ’12Q4 ’12^dQ3 ’13 Q1 ’14 Q2 ’14 Q3 ’14 Q4 ’14^d Q1 ’15…

Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes IPOs Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Changelog Circles Account Terms Privacy